Reactive oxygen species mediate functional differences in human radial and internal thoracic arteries from smokers

Journal of Vascular Surgery

Volumn 51, Issue 2, 2010, Pages 438-444

  Müller Schweinitzer, Else ^a,b   Müller, Sandra E ^c   Reineke, David C ^a   Kern, Thomas ^d   Carrel, Thierry P ^a   Eckstein, Friedrich S ^a,b   Grapow, Martin T R ^a,b  

^a UNIVERSITY OF BERN   (Switzerland)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

^c UNIVERSITY OF BASEL   (Switzerland)

^d GOETHE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; ENDOTHELIN 1; REACTIVE OXYGEN METABOLITE;

ARTICLE; BLOOD VESSEL REACTIVITY; CIGARETTE SMOKING; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY BYPASS GRAFT; HUMAN; HUMAN TISSUE; INTERNAL MAMMARY ARTERY; PRIORITY JOURNAL; RADIAL ARTERY; VASCULAR ENDOTHELIUM;

ACETYLCHOLINE; AGED; CORONARY ARTERY BYPASS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIN-1; FEMALE; HUMANS; MALE; MAMMARY ARTERIES; MICROSCOPY, CONFOCAL; MIDDLE AGED; NITROPRUSSIDE; NOREPINEPHRINE; OXIDATIVE STRESS; RADIAL ARTERY; REACTIVE OXYGEN SPECIES; SMOKING; VASOCONSTRICTION; VASOCONSTRICTOR AGENTS; VASODILATION; VASODILATOR AGENTS;

EID: 75149120239     PISSN: 07415214     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jvs.2009.09.040     Document Type: Article

References (37)

1. Ashraf M.N., Mortasawi A., Grayson A.D., and Oo A.Y. Effect of smoking status on mortality and morbidity following coronary artery bypass surgery. Thorac Cardiovasc Surg 52 (2004) 268-273
2. Papathanasiou A., Milionis H., Toumpoulis I., Kalantzi K., Katsouras C., Pappas K., et al. Smoking cessation is associated with reduced long-term mortality and the need for repeat interventions after coronary artery bypass grafting. Eur J Cardiovasc Prev Rehabil 14 (2007) 448-450
3. van Domburg R.T., Meeter K., van Berkel D.F., Veldkamp R.F., van Herwerden L.A., and Bogers A.J. Smoking cessation reduces mortality after coronary artery bypass surgery: a 20-year follow-up study. J Am Coll Cardiol 36 (2000) 878-883
4. Loop F.D., Lytle B.W., Cosgrove D.M., Stewart R.W., Goormastic M., Williams G.W., et al. Influence of the internal-mammary-artery graft on 10-year survival and other cardiac events. N Engl J Med 314 (1986) 1-6
5. Acar C., Ramsheyi A., Pagny J.Y., Jebara V., Barrier P., Fabiani J.N., et al. The radial artery for coronary artery bypass grafting: clinical and angiographic results at five years. J Thorac Cardiovasc Surg 116 (1998) 981-989
6. Khot U.N., Friedman D.T., Pettersson G., Smedira N.G., Li J., and Ellis S.G. Radial artery bypass grafts have an increased occurrence of angiographically severe stenosis and occlusion compared with left internal mammary arteries and saphenous vein grafts. Circulation 109 (2004) 2086-2091
7. Chardigny C., Jebara V.A., Acar C., Descombes J.J., Verbeuren T.J., Carpentier A., et al. Vasoreactivity of the radial artery. Comparison with the internal mammary and gastroepiploic arteries with implications for coronary artery surgery. Circulation 88 (1993) II115-II127
8. Cable D.G., Caccitolo J.A., Pfeifer E.A., Daly R.C., Dearani J.A., Mullany C.J., et al. Endothelial regulation of vascular contraction in radial and internal mammary arteries. Ann Thorac Surg 67 (1999) 1083-1090
9. Grapow M.T., Reineke D.C., Kern T., Antona C., Gelpi G., Santoli E., et al. Intraindividual comparison of human radial and internal thoracic arteries in vitro and the effect of preoperative calcium blocker therapy. Fundam Clin Pharmacol 21 (2007) 67-74
10. Grapow M.T., Reineke D.C., Kern T., Müller-Schweinitzer E., Carrel T., and Eckstein F.S. Human internal thoracic arteries (ITA) from diabetic patients are resistant to endothelial dysfunction. Fundam Clin Pharmacol 23 (2009) 567-572
11. Griendling K.K., and FitzGerald G.A. Oxidative stress and cardiovascular injury: Part I: basic mechanisms and in vivo monitoring of ROS. Circulation 108 (2003) 1912-1916
12. Griendling K.K., and FitzGerald G.A. Oxidative stress and cardiovascular injury: part II: animal and human studies. Circulation 108 (2003) 2034-2040
13. Cai H., and Harrison D.G. Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circ Res 87 (2000) 840-844
14. Czernin J., and Waldherr C. Cigarette smoking and coronary blood flow. Prog Cardiovasc Dis 45 (2003) 395-404
15. Grapow M.T., Kern T., Reineke D.C., Brett W., Bernet F., Rueter F., et al. Improved endothelial function after a modified harvesting technique of the internal thoracic artery. Eur J Cardiothorac Surg 23 (2003) 956-960 discussion 960-1
16. Bailey S.R., Mitra S., Flavahan S., and Flavahan N.A. Reactive oxygen species from smooth muscle mitochondria initiate cold-induced constriction of cutaneous arteries. Am J Physiol Heart Circ Physiol 289 (2005) H243-H250
17. Crow J.P. Dichlorodihydrofluorescein and dihydrorhodamine 123 are sensitive indicators of peroxynitrite in vitro: implications for intracellular measurement of reactive nitrogen and oxygen species. Nitric Oxide 1 (1997) 145-157
18. Seo B., Oemar B.S., Siebenmann R., von Segesser L., and Luscher T.F. Both ETA and ETB receptors mediate contraction to endothelin-1 in human blood vessels. Circulation 89 (1994) 1203-1208
19. Verma S., Lovren F., Dumont A.S., Mather K.J., Maitland A., Kieser T.M., et al. Endothelin receptor blockade improves endothelial function in human internal mammary arteries. Cardiovasc Res 49 (2001) 146-151
20. Noma K., Higashi Y., Jitsuiki D., Hara K., Kimura M., Nakagawa K., et al. Smoking activates rho-kinase in smooth muscle cells of forearm vasculature in humans. Hypertension 41 (2003) 1102-1105
21. Noma K., Goto C., Nishioka K., Hara K., Kimura M., Umemura T., et al. Smoking, endothelial function, and Rho-kinase in humans. Arterioscler Thromb Vasc Biol 25 (2005) 2630-2635
22. Fukata Y., Amano M., and Kaibuchi K. Rho-Rho-kinase pathway in smooth muscle contraction and cytoskeletal reorganization of non-muscle cells. Trends Pharmacol Sci 22 (2001) 32-39
23. Kiowski W., Linder L., Stoschitzky K., Pfisterer M., Burckhardt D., Burkart F., et al. Diminished vascular response to inhibition of endothelium-derived nitric oxide and enhanced vasoconstriction to exogenously administered endothelin-1 in clinically healthy smokers. Circulation 90 (1994) 27-34
24. Barua R.S., Ambrose J.A., Eales-Reynolds L.J., DeVoe M.C., Zervas J.G., and Saha D.C. Dysfunctional endothelial nitric oxide biosynthesis in healthy smokers with impaired endothelium-dependent vasodilatation. Circulation 104 (2001) 1905-1910
25. Barua R.S., Ambrose J.A., Saha D.C., and Eales-Reynolds L.J. Smoking is associated with altered endothelial-derived fibrinolytic and antithrombotic factors: an in vitro demonstration. Circulation 106 (2002) 905-908
26. Hamilton C.A., Williams R., Pathi V., Berg G., McArthur K., McPhaden A.R., et al. Pharmacological characterisation of endothelium-dependent relaxation in human radial artery: comparison with internal thoracic artery. Cardiovasc Res 42 (1999) 214-223
27. Shapira O.M., Xu A., Aldea G.S., Vita J.A., Shemin R.J., and Keaney Jr. J.F. Enhanced nitric oxide-mediated vascular relaxation in radial artery compared with internal mammary artery or saphenous vein. Circulation 100 (1999) II322-II327
28. Barua R.S., Ambrose J.A., Srivastava S., DeVoe M.C., and Eales-Reynolds L.J. Reactive oxygen species are involved in smoking-induced dysfunction of nitric oxide biosynthesis and upregulation of endothelial nitric oxide synthase: an in vitro demonstration in human coronary artery endothelial cells. Circulation 107 (2003) 2342-2347
29. Mahadevan V.S., Campbell M., McKeown P.P., and Bayraktutan U. Internal mammary artery smooth muscle cells resist migration and possess high antioxidant capacity. Cardiovasc Res 72 (2006) 60-68
30. Gaudino M., Toesca A., Maggiano N., Pragliola C., and Possati G. Localization of nitric oxide synthase type III in the internal thoracic and radial arteries and the great saphenous vein: a comparative immunohistochemical study. J Thorac Cardiovasc Surg 125 (2003) 1510-1515
31. Mangoush O., Athanasiou T., Nakamura K., Johnson P., Smoienski R., Sarathchandra P., et al. Antioxidant properties of the internal thoracic artery and the radial artery. Heart Lung Circ 17 (2008) 40-47
32. Mangoush O., Nakamura K., Al-Ruzzeh S., Athanasiou T., Chester A., and Amrani M. Effect of ascorbic acid on endothelium-dependent vasodilatation of human arterial conduits for coronary artery bypass grafting. Eur J Cardiothorac Surg 24 (2003) 541-546
33. Huraux C., Makita T., Kurz S., Yamaguchi K., Szlam F., Tarpey M.M., et al. Superoxide production, risk factors, and endothelium-dependent relaxations in human internal mammary arteries. Circulation 99 (1999) 53-59
34. Ozkan S., Akay T.H., Gultekin B., Aslim E., Arslan A., Ozdemir B.H., et al. Atherosclerosis of radial and internal thoracic arteries used in coronary bypass: atherosclerosis in arterial grafts. J Card Surg 22 (2007) 385-389
35. Ruengsakulrach P., Sinclair R., Komeda M., Raman J., Gordon I., and Buxton B. Comparative histopathology of radial artery versus internal thoracic artery and risk factors for development of intimal hyperplasia and atherosclerosis. Circulation 100 (1999) II139-II144
36. Al-Bustami M.H., Amrani M., Chester A.H., Ilsley C.J., and Yacoub M.H. In vivo early and mid-term flow-mediated endothelial function of the radial artery used as a coronary bypass graft. J Am Coll Cardiol 39 (2002) 573-577
37. Tatoulis J., Buxton B.F., Fuller J.A., Meswani M., Theodore S., Powar N., et al. Long-term patency of 1108 radial arterial-coronary angiograms over 10 years. Ann Thorac Surg 88 (2009) 23-29 discussion 29-30